Back to Search
Start Over
Tracing the Origin of Cell-Free DNA Molecules through Tissue-Specific Epigenetic Signatures.
- Source :
- Diagnostics (2075-4418); Aug2022, Vol. 12 Issue 8, p1834-N.PAG, 26p
- Publication Year :
- 2022
-
Abstract
- All cell and tissue types constantly release DNA fragments into human body fluids by various mechanisms including programmed cell death, accidental cell degradation and active extrusion. Particularly, cell-free DNA (cfDNA) in plasma or serum has been utilized for minimally invasive molecular diagnostics. Disease onset or pathological conditions that lead to increased cell death alter the contribution of different tissues to the total pool of cfDNA. Because cfDNA molecules retain cell-type specific epigenetic features, it is possible to infer tissue-of-origin from epigenetic characteristics. Recent research efforts demonstrated that analysis of, e.g., methylation patterns, nucleosome occupancy, and fragmentomics determined the cell- or tissue-of-origin of individual cfDNA molecules. This novel tissue-of origin-analysis enables to estimate the contributions of different tissues to the total cfDNA pool in body fluids and find tissues with increased cell death (pathologic condition), expanding the portfolio of liquid biopsies towards a wide range of pathologies and early diagnosis. In this review, we summarize the currently available tissue-of-origin approaches and point out the next steps towards clinical implementation. [ABSTRACT FROM AUTHOR]
- Subjects :
- CELL-free DNA
CIRCULATING tumor DNA
APOPTOSIS
MOLECULES
EPIGENETICS
HUMAN body
Subjects
Details
- Language :
- English
- ISSN :
- 20754418
- Volume :
- 12
- Issue :
- 8
- Database :
- Complementary Index
- Journal :
- Diagnostics (2075-4418)
- Publication Type :
- Academic Journal
- Accession number :
- 158807222
- Full Text :
- https://doi.org/10.3390/diagnostics12081834